A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

Investors interested in arranging a meeting with the Company’s management during the conference can register on the BIO CEO & Investor Conference website here.

A mother wants to respect her 2½-year-old’s preference for dressing like his older sister, but she worries that letting him do so would bother the bridal couple.

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced ...

The Food and Drug Administration (FDA) recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline ...

We’re near the bear’s den,” Cross whispers. “We need to spread out and move as quietly as possible.” Several days earlier, ...

As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, with health experts warning ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato ... It is now approved for adults with treatment-resistant depression (TRD) who have cycled through multiple treatments ...